{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:46:28Z","timestamp":1794584788961,"version":"4.9.1"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013993","name":"Theravance Biopharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013993","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL144568"],"award-info":[{"award-number":["HL144568"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL149386"],"award-info":[{"award-number":["HL149386"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL122847"],"award-info":[{"award-number":["HL122847"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK11175"],"award-info":[{"award-number":["DK11175"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013327","name":"H. Lundbeck A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["autonomicneuroscience.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autonomic Neuroscience"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.autneu.2020.102721","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T22:03:32Z","timestamp":1598565812000},"page":"102721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Pharmacologic treatment of orthostatic hypotension"],"prefix":"10.1016","volume":"229","author":[{"given":"Jin-Woo","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis E.","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyndya A.","family":"Shibao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Italo","family":"Biaggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autneu.2020.102721_bb0005","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1080\/10826070701540605","article-title":"Analysis of pyridostigmine bromide in human plasma and its application in bioequivalence studies","volume":"30","author":"Agarwal","year":"2007","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.autneu.2020.102721_bb0010","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/MNH.0b013e328356c52f","article-title":"Management approaches to hypertension in autonomic failure","volume":"21","author":"Arnold","year":"2012","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.autneu.2020.102721_bb0015","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s11906-013-0362-3","article-title":"Current concepts in orthostatic hypotension management","volume":"15","author":"Arnold","year":"2013","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.autneu.2020.102721_bb0020","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/HYPERTENSIONAHA.111.00377","article-title":"Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure","volume":"61","author":"Arnold","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.autneu.2020.102721_bb0025","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.115.06617","article-title":"Mineralocorticoid receptor activation contributes to the supine hypertension of autonomic failure","volume":"67","author":"Arnold","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.autneu.2020.102721_bb0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1212\/CON.0000000000000817","article-title":"Physiology and pathophysiology of the autonomic nervous system","volume":"26","author":"Benarroch","year":"2020","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.autneu.2020.102721_bb0035","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/BF02532418","article-title":"Aromatic L-amino acid decarboxylase: a neglected and misunderstood enzyme","volume":"21","author":"Berry","year":"1996","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.autneu.2020.102721_bb0040","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s11886-014-0542-z","article-title":"New developments in the management of neurogenic orthostatic hypotension","volume":"16","author":"Biaggioni","year":"2014","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.autneu.2020.102721_bb0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/pr.115.012161","article-title":"The pharmacology of autonomic failure: from hypotension to hypertension","volume":"69","author":"Biaggioni","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.autneu.2020.102721_bb0050","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12883-017-0867-5","article-title":"Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension","volume":"17","author":"Biaggioni","year":"2017","journal-title":"BMC Neurol."},{"key":"10.1016\/j.autneu.2020.102721_bb0055","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1212\/WNL.0000000000004340","article-title":"Efficacy of single or combined midodrine and pyridostigmine in orthostatic hypotension","volume":"89","author":"Byun","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.autneu.2020.102721_bb0060","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/acn3.50968","article-title":"Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension","volume":"7","author":"Byun","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.autneu.2020.102721_bb0065","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/bmj.1.6014.872","article-title":"Therapeutic experience with fludrocortisone in diabetic postural hypotension","volume":"1","author":"Campbell","year":"1976","journal-title":"Br. Med. J."},{"key":"10.1016\/j.autneu.2020.102721_bb0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s40268-018-0226-z","article-title":"Comparison of the pharmacokinetics of droxidopa after dosing in the fed versus fasted state and with 3-times-daily dosing in healthy elderly subjects","volume":"18","author":"Chen","year":"2018","journal-title":"Drugs R D"},{"key":"10.1016\/j.autneu.2020.102721_bb0075","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.27186","article-title":"Neuropathology of autonomic dysfunction in synucleinopathies","volume":"33","author":"Coon","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.autneu.2020.102721_bb0080","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S1474-4422(16)30079-5","article-title":"Neurogenic orthostatic hypotension and supine hypertension in Parkinson\u2019s disease and related synucleinopathies: prioritisation of treatment targets","volume":"15","author":"Espay","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.autneu.2020.102721_bb0085","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10286-018-0529-8","volume":"28","author":"Fanciulli","year":"2018","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.autneu.2020.102721_bb0090","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2147\/DMSO.S129797","article-title":"Cardiac autonomic neuropathy in patients with diabetes mellitus: current perspectives","volume":"10","author":"Fisher","year":"2017","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.autneu.2020.102721_bb0095","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/mdc3.12726","article-title":"Six-month use of droxidopa for neurogenic orthostatic hypotension","volume":"6","author":"Francois","year":"2019","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.autneu.2020.102721_bb0100","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.autneu.2011.02.004","article-title":"Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome","volume":"161","author":"Freeman","year":"2011","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.autneu.2020.102721_bb0105","doi-asserted-by":"crossref","first-page":"H1438","DOI":"10.1152\/ajpheart.01020.2011","article-title":"Sympathetic activation and nitric oxide function in early hypertension","volume":"302","author":"Gamboa","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.autneu.2020.102721_bb0110","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/HYPERTENSIONAHA.109.136853","article-title":"Renal impairment of pure autonomic failure","volume":"54","author":"Garland","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.autneu.2020.102721_bb0115","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jdiacomp.2015.08.020","article-title":"Orthostatic hypotension in diabetic patients-10-year follow-up study","volume":"30","author":"Gaspar","year":"2016","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.autneu.2020.102721_bb0120","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00415-016-8375-x","article-title":"The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension","volume":"264","author":"Gibbons","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.autneu.2020.102721_bb0125","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006848","article-title":"Fludrocortisone is associated with a higher risk of all-cause hospitalizations compared with midodrine in patients with orthostatic hypotension","volume":"6","author":"Grijalva","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.autneu.2020.102721_bb0130","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.beem.2013.06.004","article-title":"Determination of catecholamines in plasma and urine","volume":"27","author":"Grouzmann","year":"2013","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.autneu.2020.102721_bb0135","series-title":"Primer on the Autonomic Nervous System","first-page":"280","article-title":"Norepinephrine transporter dysfunction","author":"Hahn","year":"2004"},{"key":"10.1016\/j.autneu.2020.102721_bb0140","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1136\/gut.35.3_Suppl.S1","article-title":"Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects","volume":"35","author":"Harris","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.autneu.2020.102721_bb0145","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1056\/NEJM195910152611604","article-title":"Successful treatment of orthostatic hypotension with 9-alpha-fluorohydrocortisone","volume":"261","author":"Hickler","year":"1959","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.autneu.2020.102721_bb0150","doi-asserted-by":"crossref","first-page":"e1526","DOI":"10.1212\/WNL.0000000000008314","article-title":"Orthostatic hypotension in Parkinson disease: a 7-year prospective population-based study","volume":"93","author":"Hiorth","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.autneu.2020.102721_bb0155","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/archneur.1975.00490430072013","article-title":"Levodopa-induced postural hypotension. Treatment with fludrocortisone","volume":"32","author":"Hoehn","year":"1975","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.autneu.2020.102721_bb0160","first-page":"339","article-title":"Treatment of orthostatic hypotension with midodrine and octreotide","volume":"83","author":"Hoeldtke","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.autneu.2020.102721_bb0165","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/01.CIR.99.13.1706","article-title":"Abnormal norepinephrine clearance and adrenergic receptor sensitivity in idiopathic orthostatic intolerance","volume":"99","author":"Jacob","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.autneu.2020.102721_bb0170","doi-asserted-by":"crossref","first-page":"286","DOI":"10.7326\/0003-4819-122-4-199502150-00009","article-title":"Postprandial hypotension: epidemiology, pathophysiology, and clinical management","volume":"122","author":"Jansen","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.autneu.2020.102721_bb0175","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10286-015-0271-4","article-title":"Multiple system atrophy: using clinical pharmacology to reveal pathophysiology","volume":"25","author":"Jordan","year":"2015","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.autneu.2020.102721_bb0180","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/HJH.0000000000002078","article-title":"Management of supine hypertension in patients with neurogenic orthostatic hypotension: scientific statement of the American Autonomic Society, European Federation of Autonomic Societies, and the European Society of Hypertension","volume":"37","author":"Jordan","year":"2019","journal-title":"J. Hypertens."},{"key":"10.1016\/j.autneu.2020.102721_bb0185","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.CIR.0000083721.49847.D7","article-title":"Norepinephrine precursor therapy in neurogenic orthostatic hypotension","volume":"108","author":"Kaufmann","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.autneu.2020.102721_bb0190","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.clinthera.2008.09.001","article-title":"Pharmacokinetic and pharmacodynamic effects of midodrine on blood pressure, the autonomic nervous system, and plasma natriuretic peptides: a prospective, randomized, single-blind, two-period, crossover, placebo-controlled study","volume":"30","author":"Lamarre-Cliche","year":"2008","journal-title":"Clin. Ther."},{"key":"10.1016\/j.autneu.2020.102721_bb0195","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1056\/NEJM199601253340408","article-title":"Octreotide","volume":"334","author":"Lamberts","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.autneu.2020.102721_bb0200","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jama.1997.03540370036033","article-title":"Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group","volume":"277","author":"Low","year":"1997","journal-title":"Jama"},{"key":"10.1016\/j.autneu.2020.102721_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3988\/jcn.2013.9.1.1","article-title":"Autonomic function tests: some clinical applications","volume":"9","author":"Low","year":"2013","journal-title":"J. Clin. Neurol."},{"issue":"281","key":"10.1016\/j.autneu.2020.102721_bb0210","first-page":"e281","article-title":"Postprandial hypotension","volume":"123","author":"Luciano","year":"2010","journal-title":"Am. J. Med."},{"key":"10.1016\/j.autneu.2020.102721_bb0215","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/jch.13619","article-title":"Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients","volume":"21","author":"McDonell","year":"2019","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"10.1016\/j.autneu.2020.102721_bb0220","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/mds.23744","article-title":"Does cardiovascular autonomic dysfunction contribute to fatigue in Parkinson\u2019s disease?","volume":"26","author":"Nakamura","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.autneu.2020.102721_bb0225","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF02281627","article-title":"Clinical and physiological characteristics of autonomic failure with Parkinson\u2019s disease","volume":"9","author":"Niimi","year":"1999","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.autneu.2020.102721_bb0230","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ana.25170","article-title":"Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies","volume":"83","author":"Norcliffe-Kaufmann","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.autneu.2020.102721_bb9000","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.111.184812","article-title":"Synergistic effects of norepinephrine transporter blockade and alpha-2 antagonism on blood pressure in autonomic failure","volume":"59","author":"Okamoto","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.autneu.2020.102721_bb0235","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1161\/HYPERTENSIONAHA.114.04116","article-title":"Nebivolol, but not metoprolol, lowers blood pressure in nitric oxide-sensitive human hypertension","volume":"64","author":"Okamoto","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.autneu.2020.102721_bb0240","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/HYPERTENSIONAHA.116.07199","article-title":"Efficacy of servo-controlled splanchnic venous compression in the treatment of orthostatic hypotension: a randomized comparison with midodrine","volume":"68","author":"Okamoto","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.autneu.2020.102721_bb0245","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/HYPERTENSIONAHA.118.11790","article-title":"Synergistic pressor effect of atomoxetine and pyridostigmine in patients with neurogenic orthostatic hypotension","volume":"73","author":"Okamoto","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.autneu.2020.102721_bb0250","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.amjcard.2020.01.037","article-title":"Cardiovascular safety considerations in the treatment of neurogenic orthostatic hypotension","volume":"125","author":"Olshansky","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.autneu.2020.102721_bb0255","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJM198508293130905","article-title":"Hemodynamic and humoral effects of caffeine in autonomic failure. Therapeutic implications for postprandial hypotension","volume":"313","author":"Onrot","year":"1985","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.autneu.2020.102721_bb0260","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/mdc3.12478","article-title":"Epidemiology, diagnosis, and management of neurogenic orthostatic hypotension","volume":"4","author":"Palma","year":"2017","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.autneu.2020.102721_bb0265","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1212\/CON.0000000000000816","article-title":"Management of orthostatic hypotension","volume":"26","author":"Palma","year":"2020","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.autneu.2020.102721_bb0270","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cger.2019.09.002","article-title":"Orthostatic hypotension in Parkinson disease","volume":"36","author":"Palma","year":"2020","journal-title":"Clin. Geriatr. Med."},{"key":"10.1016\/j.autneu.2020.102721_bb0275","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: a position statement by the American Diabetes Association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autneu.2020.102721_bb0280","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1161\/HYPERTENSIONAHA.114.04225","article-title":"Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure","volume":"64","author":"Ramirez","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.autneu.2020.102721_bb0285","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cca.2012.11.026","article-title":"Human plasma quantification of fludrocortisone using liquid chromatography coupled with atmospheric pressure chemical ionization mass spectrometry after low-dosage administration","volume":"420","author":"Ribot","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.autneu.2020.102721_bb0290","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/eurheartj\/ehv093","article-title":"Cardiovascular morbidity and mortality related to orthostatic hypotension: a meta-analysis of prospective observational studies","volume":"36","author":"Ricci","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.autneu.2020.102721_bb0295","series-title":"Primer on the Autonomic Nervous System","first-page":"411","article-title":"Fludrocortisone","author":"Robertson","year":"2004"},{"issue":"Suppl. 1","key":"10.1016\/j.autneu.2020.102721_bb0300","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s10286-007-1004-0","article-title":"The pathophysiology and diagnosis of orthostatic hypotension","volume":"18","author":"Robertson","year":"2008","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.autneu.2020.102721_bb0305","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/ene.13260","article-title":"Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson\u2019s disease - a randomized controlled trial","volume":"24","author":"Schreglmann","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.autneu.2020.102721_bb0310","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1161\/01.HYP.30.5.1062","article-title":"The hypertension of autonomic failure and its treatment","volume":"30","author":"Shannon","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.autneu.2020.102721_bb0315","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0002-9343(02)01025-2","article-title":"Water drinking as a treatment for orthostatic syndromes","volume":"112","author":"Shannon","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.autneu.2020.102721_bb0320","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/01.HYP.0000199982.71858.11","article-title":"Clonidine for the treatment of supine hypertension and pressure natriuresis in autonomic failure","volume":"47","author":"Shibao","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.autneu.2020.102721_bb0325","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/HYPERTENSIONAHA.107.091355","article-title":"Acarbose, an alpha-glucosidase inhibitor, attenuates postprandial hypotension in autonomic failure","volume":"50","author":"Shibao","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.autneu.2020.102721_bb0330","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.amjmed.2007.05.009","article-title":"Orthostatic hypotension-related hospitalizations in the United States","volume":"120","author":"Shibao","year":"2007","journal-title":"Am. J. Med."},{"key":"10.1016\/j.autneu.2020.102721_bb0335","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/HYPERTENSIONAHA.107.089961","article-title":"Norepinephrine transporter blockade with atomoxetine induces hypertension in patients with impaired autonomic function","volume":"50","author":"Shibao","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.autneu.2020.102721_bb0340","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/HYPERTENSIONAHA.110.154898","article-title":"Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure","volume":"56","author":"Shibao","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.autneu.2020.102721_bb0345","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pharmthera.2011.05.009","article-title":"Pharmacotherapy of autonomic failure","volume":"134","author":"Shibao","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.autneu.2020.102721_bb0350","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2165\/00003495-200464020-00005","article-title":"Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder","volume":"64","author":"Simpson","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.autneu.2020.102721_bb0355","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1136\/jnnp.74.9.1294","article-title":"Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension","volume":"74","author":"Singer","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.autneu.2020.102721_bb0360","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archneur.63.4.noc50340","article-title":"Pyridostigmine treatment trial in neurogenic orthostatic hypotension","volume":"63","author":"Singer","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.autneu.2020.102721_bb0365","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1007\/s11606-014-3014-7","article-title":"Midodrine efficacy in orthostatic hypotension","volume":"29","author":"Singer","year":"2014","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.autneu.2020.102721_bb0370","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.2337\/dc08-0107","article-title":"Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS)","volume":"31","author":"Soedamah-Muthu","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autneu.2020.102721_bb0375","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0163-7258(01)00156-5","article-title":"Yohimbine: a clinical review","volume":"91","author":"Tam","year":"2001","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.autneu.2020.102721_bb0380","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2796.1992.tb00563.x","article-title":"Treatment of orthostatic hypotension with sleeping in the head-up tilt position, alone and in combination with fludrocortisone","volume":"232","author":"Ten Harkel","year":"1992","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.autneu.2020.102721_bb0385","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(99)05320-9","article-title":"Hypertensive cardiovascular damage in patients with primary autonomic failure","volume":"355","author":"Vagaonescu","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.autneu.2020.102721_bb0390","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1212\/01.wnl.0000184504.13173.ef","article-title":"Blood pressure recovery from Valsalva maneuver in patients with autonomic failure","volume":"65","author":"Vogel","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.autneu.2020.102721_bb0395","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1212\/WNL.51.1.120","article-title":"A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension","volume":"51","author":"Wright","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.autneu.2020.102721_bb0400","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/clpt.1986.101","article-title":"Pharmacodynamics of midodrine, an antihypotensive agent","volume":"39","author":"Zachariah","year":"1986","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.autneu.2020.102721_bb0405","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/jim-2016-000295","article-title":"Effectiveness of acarbose in treating elderly patients with diabetes with postprandial hypotension","volume":"65","author":"Zhang","year":"2017","journal-title":"J. Investig. Med."}],"container-title":["Autonomic Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1566070220301557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1566070220301557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:40:49Z","timestamp":1778618449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1566070220301557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":82,"alternative-id":["S1566070220301557"],"URL":"https:\/\/doi.org\/10.1016\/j.autneu.2020.102721","relation":{},"ISSN":["1566-0702"],"issn-type":[{"value":"1566-0702","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic treatment of orthostatic hypotension","name":"articletitle","label":"Article Title"},{"value":"Autonomic Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autneu.2020.102721","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102721"}}